%20INC./other/GINWA_ENTERPRISE_GROUP_INC.-logo.png)
GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings
Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于2020年半年度募集资金度存放与使用情况的专项报告 | 2020-08-14 | Chinese | |
| 关于2019年度审计报告保留意见涉及事项影响已消除的审核报告 | 2020-08-14 | Chinese | |
| 关于收到中国证券监督管理委员会陕西监管局《行政处罚决定书》的公告 | 2020-08-05 | Chinese | |
| 关于收到中国证券监督管理委员会陕西监管局《行政监管措施决定书》的公告 | 2020-08-05 | Chinese | |
| 独立董事关于会计差错更正的意见 | 2020-07-31 | Chinese | |
| 关于会计差错更正的公告 | 2020-07-31 | Chinese |
Browse filings by year
26 years- 2026 57 filings
- 2025 109 filings
- 2024 101 filings
- 2023 125 filings
- 2022 133 filings
- 2021 103 filings
- 2020 144 filings
- 2019 67 filings
- 2018 80 filings
- 2017 105 filings
- 2016 103 filings
- 2015 54 filings
- 2014 47 filings
- 2013 28 filings
- 2012 35 filings
- 2011 44 filings
- 2010 30 filings
- 2009 42 filings
- 2008 62 filings
- 2007 75 filings
- 2006 62 filings
- 2005 37 filings
- 2004 21 filings
- 2003 16 filings
- 2002 29 filings
- 2001 6 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 40276064 | 关于2020年半年度募集资金度存放与使用情况的专项报告 | 2020-08-14 | Chinese | ||
| 40276056 | 关于2019年度审计报告保留意见涉及事项影响已消除的审核报告 | 2020-08-14 | Chinese | ||
| 40276043 | 关于收到中国证券监督管理委员会陕西监管局《行政处罚决定书》的公告 | 2020-08-05 | Chinese | ||
| 40276031 | 关于收到中国证券监督管理委员会陕西监管局《行政监管措施决定书》的公告 | 2020-08-05 | Chinese | ||
| 40276023 | 独立董事关于会计差错更正的意见 | 2020-07-31 | Chinese | ||
| 40276013 | 关于会计差错更正的公告 | 2020-07-31 | Chinese | ||
| 40275999 | 关于收到中国证券监督管理委员会陕西监管局《行政处罚事先告知书》的公告 | 2020-07-30 | Chinese | ||
| 40275985 | 2019年年度权益分派实施公告 | 2020-07-22 | Chinese | ||
| 40275973 | 关于上海证券交易所问询函的回复公告 | 2020-07-06 | Chinese | ||
| 40275955 | 简式权益变动报告书-邢博越(修订) | 2020-07-06 | Chinese | ||
| 40275947 | 关于上海证券交易所问询函的复函-金花投资控股集团有限公司 | 2020-07-06 | Chinese | ||
| 40275935 | 关于上海证券交易所问询函的复函-邢博越 | 2020-07-06 | Chinese | ||
| 40275905 | 关于控股股东所持公司部分股份被司法拍卖完成过户的公告 | 2020-07-03 | Chinese | ||
| 40275893 | 关于收到上海证券交易所对股东权益变动事项问询函的公告 | 2020-07-02 | Chinese | ||
| 40275885 | 简式权益变动报告书-邢博越(修订) | 2020-07-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GINWA ENTERPRISE (GROUP) INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56468/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56468 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56468 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56468 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56468}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GINWA ENTERPRISE (GROUP) INC. (id: 56468)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.